Markets
Is TCR2 Therapeutics Inc. (NASDAQ:TCRR) Still Worth A Bite?
TCR2 Therapeutics Inc. (NASDAQ:TCRR) previous close was $19.21 while the outstanding shares total 37.06M. TCRR’s shares traded lower over the last trading session, losing -0.05%